Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
about
Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer's diseaseA chemokine self-presentation mechanism involving formation of endothelial surface microstructuresCharacterization of anticoagulant heparinoids by immunoprofiling.ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican.Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancerEndothelial and leukocyte heparan sulfates regulate the development of allergen-induced airway remodeling in a mouse modelDeficiency of endothelial heparan sulfates attenuates allergic airway inflammation.Peptide-displaying phage technology in glycobiologyOrgan-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in miceThe heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera.Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding.Dermatan Sulfate-Free Mice Display Embryological Defects and Are Neonatal Lethal Despite Normal Lymphoid and Non-Lymphoid OrganogenesisAge-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfationDirect visualization of specifically modified extracellular glycans in living animals.Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposureCancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity.Characterization of the interaction between the chlamydial adhesin OmcB and the human host cell.Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end.Drug-Mediated Regulation of Glycosaminoglycan Biosynthesis.Extracellular sugar modifications provide instructive and cell-specific information for axon-guidance choicesHeparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificitiesGlycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulfate/dermatan sulfate.Desulfation of Heparan Sulfate by Sulf1 and Sulf2 Is Required for Corticospinal Tract Formation.A transgenic approach to live imaging of heparan sulfate modification patterns.Heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, regulate glomerular integrity by modulating growth factor signaling.Expression of heparan sulfate proteoglycans in murine models of experimental colitis.Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphation
P2860
Q26992202-630B7270-4F1C-4E2B-A8F4-526A6CBFA06BQ30540297-8A74363E-FA4C-47F4-9A50-4300AB4B4CD8Q33376879-BA3814DE-41E5-4C7A-BD81-B3E8BDFABD06Q33506936-1828EC21-59D6-49FA-9C75-751982C5D809Q33803148-7B595002-3A86-439E-B4BE-F1A16AD6EBCEQ33806763-46DAADCD-F1C3-44DE-8F94-A082C6D1EC8BQ33857916-61AB2F52-F483-42A8-941A-D47FDD1085FBQ34022620-B34353BE-A237-4465-BA4A-9E7C4749DC7CQ34251345-DA026D6A-9B8C-442A-A29E-992D190A7AA0Q34412830-301767B4-2C27-42BC-A0B1-0368D804C0FCQ34757062-3A1D1488-C227-495B-922A-0DCED237E2ADQ35221119-A1D52698-66B9-42A1-8CE9-2FB8093A7A9BQ35624698-11746FCF-C4C7-4D4A-B4DE-7DA3FCA79AF0Q35816218-80043DF9-6913-41BC-BC8D-8CDDA548DF03Q35879491-0153149F-0320-41B4-B762-B281CCA9D775Q36222320-D37B3F87-8C1F-4C9A-9A75-3FE17215A964Q36517471-007FF90C-45D0-4639-86CB-890CCF89E5D2Q37256065-5708393F-A96C-4861-AAAC-C9505AD88581Q37335962-4D1720BE-1C3F-4E4C-9787-8731E46F06BEQ38770928-8A9610FA-930B-4D77-9779-8C15E4C1B33AQ38995855-5B5BAB79-9067-4694-9584-19ADECC2421EQ39060517-E1C9AE8B-871B-4934-BD61-429FAE164119Q42047138-5B635DDE-A02D-46D1-9298-118E563987D5Q42276329-77FB2763-DFA8-4CB2-BB99-E01A819523BCQ42670912-4D252AC4-E654-4A28-A050-FA7E5EB8DC7FQ42975266-2CDCD22E-D1ED-4683-A5C9-DB1DFF26068EQ44130592-7346E499-782A-49C8-9C5F-F8F620BBFF53Q52667051-07028D64-647B-4B34-BCC1-C320FA81E4A5Q54344427-24467597-56D3-439C-A5A4-44FE79855BB9Q54888139-98428B40-98BC-40D9-A6D3-FBC810E1253B
P2860
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
@ast
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
@en
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
@nl
type
label
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
@ast
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
@en
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
@nl
prefLabel
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
@ast
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
@en
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
@nl
P2093
P2860
P356
P1476
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
@en
P2093
Dorothe Spillmann
Guido J Jenniskens
Hiroko Habuchi
Jin-Ping Li
Koji Kimata
Sindhulakshmi Kurup
Tessa J M Wijnhoven
Toin H van Kuppevelt
P2860
P304
21032-21042
P356
10.1074/JBC.M702073200
P407
P50
P577
2007-05-21T00:00:00Z